In recent years, Type 2 diabetes has become quite prevalent over a wide variety of patient demographics. To that end, many new medications have also been created to ease symptoms and maintain patient health. Unfortunately, those same medications can sometimes pose a large number of undesirable or dangerous side effects. One such medication is known as canagliflozin. This prescription may also be known under names including Invokamet and Invokana. Under normal circumstances, canagliflozin is used in conjunction with a healthy diet and exercise to maintain proper therapy for the diabetic patient. However, several studies have observed a rise in bone density loss with use of this drug. One such assessment was conducted by the Food and Drug Administration (FDA) to ensure patient safety. Along with the possibility of losing valuable bone minerals, canagliflozin has also been connected to a greater risk of bone fractures for those using this prescription in a long-term capacity. The studies have further shown that particular areas of concern seem to center around the hip and spine for potential injuries and fractures.

The FDA has thus far issued a preemptive step by expanding and further elaborating on the packages and warning labels for this medicine. For best results, patients should follow up with their physicians or healthcare providers to evaluate their own risks and benefits in taking this medication. Some items to reflect upon would include any pre-existing conditions patients may have that could lead to fractures and the length of time patients have been on this drug. Since complications have been noted in some patients as early as the 12th week after beginning therapy, a thorough review of the patient’s medical history and a holistic overview can possibly stave off any problems. It may also be of interest to observe that other drugs in the same class, such as SGLT2 inhibitor class medicines, have been seen to have the same type of side effects, and so these should be monitored closely as well.

Since stopping these medications can be a dangerous endeavor, clients who are concerned should immediately contact their healthcare providers to determine the best course for their personal therapy for the future. Diabetes can lead to blindness, heart problems, circulatory problems, and more, so maintaining some method of treatment is essential for anyone diagnosed as a Type 2 diabetic. With a solid protocol of education and knowledge, in conjunction with open communication with healthcare providers, patients can readily find the most efficient treatment for their personal situations.

For those who have experienced adverse side effects from these medicines, it is important to report such to the FDA as well as the patient’s personal physician. Those who have ongoing or permanent damage from using these treatments may also wish to contact an attorney as necessary. A competent and dedicated attorney can determine if there has been misconduct, misdiagnosis, or side effects that can receive financial or legal relief. Such reports can also ensure that future patients will not have to endure these same scenarios as drugs and treatments are revised and refined.